DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Shaw AT, Kim TM, Crinò L. et al.
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.

Lancet Oncol 2017;
18 (07) 874-886

Download Bibliographical Data

Access:
Access: